Review: taking Warfarin sodium and Vitamin d together


Summary

Drug interactions are reported among people who take Warfarin sodium and Vitamin d together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Vitamin d. It is created by eHealthMe based on reports of 1,695 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Warfarin sodium and Vitamin d >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 49,826 users)

Vitamin D

Vitamin d has active ingredients of ergocalciferol. It is often used in rickets. (latest outcomes from Vitamin d 13,625 users)

On Aug, 21, 2016

1,695 people who take Warfarin Sodium, Vitamin D are studied.


Number of reports submitted per year:

Warfarin sodium and Vitamin d drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 70.0% - (7 of 10 people)
  • 6 - 12 months: 57.0% - (4 of 7 people)
  • 1 - 2 years: 57.0% - (4 of 7 people)
  • 2 - 5 years: 63.0% - (7 of 11 people)
  • 5 - 10 years: 83.0% - (10 of 12 people)
  • 10+ years: 90.0% - (10 of 11 people)
  • not specified: 0.0% - (0 of 0 people)
Vitamin D:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 46.0% - (6 of 13 people)
  • 6 - 12 months: 25.0% - (2 of 8 people)
  • 1 - 2 years: 42.0% - (6 of 14 people)
  • 2 - 5 years: 44.0% - (4 of 9 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 60.0% - (3 of 5 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 71.0% - (25 of 35 people)
  • male: 72.0% - (18 of 25 people)
Vitamin D:
  • female: 46.0% - (13 of 28 people)
  • male: 38.0% - (10 of 26 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 62.0% - (5 of 8 people)
  • 50-59: 66.0% - (12 of 18 people)
  • 60+: 77.0% - (24 of 31 people)
Vitamin D:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 14.0% - (1 of 7 people)
  • 50-59: 60.0% - (9 of 15 people)
  • 60+: 40.0% - (12 of 30 people)

Most common drug interactions over time *:

< 1 month:
  • haemoglobin decreased
  • hypertension
  • international normalised ratio increased
  • pancytopenia
  • platelet count decreased
  • rhabdomyolysis
  • sepsis
  • white blood cell count decreased
  • blood creatinine increased
  • headache
1 - 6 months:
  • hepatitis acute
  • dizziness
  • female genital tract fistula
  • international normalised ratio increased
  • parkinsonism
  • skin blushing/flushing
  • urinary tract infection
  • asthenia
  • confusional state
  • constipation
6 - 12 months:
  • pancytopenia
  • sepsis
  • dizziness
  • electrolyte imbalance
  • stroke
  • pneumonitis
  • cardiac arrest
  • fall
  • foot, leg, and ankle swelling
  • gerd
1 - 2 years:
  • diarrhoea
  • hives
  • itching
  • muscle oedema
  • rash generalised
  • urticaria
  • hyperlipidaemia
  • hypertension
  • cough aggravated
  • delayed gastric emptying
2 - 5 years:
  • muscle twitching
  • dizziness
  • short-term memory loss
  • depression
  • cognitive deterioration
  • diarrhoea
  • fatigue - chronic
  • gait abnormal
  • hyperacusis
  • hyporeflexia
5 - 10 years:
  • weakness
  • cognitive deterioration
  • depression
  • dizziness
  • fatigue - chronic
  • gait abnormal
  • hyperacusis
  • hyporeflexia
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle twitching
10+ years:
  • hives
  • itching
  • rash generalised
  • urticaria
  • erectile dysfunction
  • liver function tests nos abnormal
  • anaemia
  • blood pressure systolic inspiratory decreased
  • cerebral haemangioma
  • constipation aggravated
not specified:
  • pain
  • dyspnoea
  • fatigue
  • fall
  • diarrhoea
  • headache
  • pneumonia
  • atrial fibrillation
  • nausea
  • hypertension

Most common drug interactions by gender *:

female:
  • pain
  • dyspnoea
  • diarrhoea
  • headache
  • fall
  • atrial fibrillation
  • fatigue
  • pneumonia
  • nausea
  • arthralgia
male:
  • fatigue
  • fall
  • dyspnoea
  • international normalised ratio increased
  • pain
  • anaemia
  • asthenia
  • dizziness
  • pneumonia
  • nausea

Most common drug interactions by age *:

2-9:
  • adrenocortical insufficiency acute
  • international normalised ratio increased
  • anaemia
  • drug administration error
  • dysphonia
  • fall
  • femur fracture
  • headache
  • hip fracture
  • hyponatraemia
10-19:
  • abdominal pain
  • bronchitis
  • depression
  • dyspnoea
  • fatigue
  • thrombosis
  • abdominal mass
  • abdominal pain upper
  • actinomycosis
  • albumin globulin ratio decreased
20-29:
  • pyrexia
  • arthralgia
  • diarrhoea
  • nausea
  • fall
  • pleural effusion
  • constipation
  • pain
  • urinary retention
  • vomiting
30-39:
  • dyspnoea
  • nausea
  • vomiting
  • pain in extremity
  • back pain
  • anxiety
  • renal failure acute
  • bone disorder
  • chest pain
  • chronic obstructive pulmonary disease
40-49:
  • pain in extremity
  • dyspepsia
  • headache
  • anxiety
  • bone disorder
  • chest pain
  • dizziness
  • dyspnoea
  • gastritis
  • nausea
50-59:
  • dyspnoea
  • dizziness
  • pain
  • diarrhoea
  • hepatitis acute
  • nausea
  • anaemia
  • anxiety
  • osteoarthritis
  • pancytopenia
60+:
  • pain
  • fall
  • fatigue
  • atrial fibrillation
  • diarrhoea
  • asthenia
  • dyspnoea
  • headache
  • pneumonia
  • hypertension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Vitamin d?

Can you answer these questions?

More questions for: Warfarin sodium, Vitamin d

You may be interested in these reviews

More reviews for: Warfarin sodium, Vitamin d

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Vitamin d (ergocalciferol) is often used to treat rickets. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.